Glioma clinical trials in California
25 studies for Glioma are looking for participants at sites in California.
Cities in California
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- and 7 more
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Sep 30, 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UCSD Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University, Palo Alto
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
RecruitingPhase 1/2
Up to age 25 · All sexes · Updated Sep 25, 2026 · NCT04094610Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Cedars-Sinai Medical Center, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT04977375A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
- Children's Hospital Orange County (CHOC), Orange
RecruitingPhase 1
Ages 5 to 18 · All sexes · Updated Sep 15, 2026 · NCT06357377Assessing Brain Metabolism Using MRS With Deuterated Glucose
- University of California, San Francisco, San Francisco
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06594315SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of California San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
- Hoag Memorial Hospital Presbyterian, Newport Beach
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's Hospital Los Angeles, Los Angeles
- University of California, San Diego Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 1 to 25 · All sexes · Updated Aug 18, 2026 · NCT04485559Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Los Angeles
- Research Site, San Francisco
RecruitingPhase 1/2
Ages 18 to 130 · All sexes · Updated Aug 12, 2026 · NCT05417594Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- UCI Irvine Health, Orange
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07486713A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
- University of California Irvine, Orange
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05916313Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07628634A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Imaging of Solid Tumors Using 18F-TRX
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06942104Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- Stanford University School of Medicine, Palo Alto
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT03510208Hyperpolarized Imaging in Diagnosing Participants With Glioma
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Jun 18, 2026 · NCT03739411Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
- Moores Cancer Center, San Diego
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Jun 10, 2026 · NCT05576103Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT04540107A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- UCLA Hematology/Oncology, Westwood, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT06326411Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of California, Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California at San Francisco, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Children's Health Orange County (CHOC), Orange
RecruitingPhase 1
12 Months – 18 Years · All sexes · Updated Mar 17, 2026 · NCT04943848DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- University of Southern California, Los Angeles
- University of California, San Diego, San Diego
- University of California, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06504381Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06650163MCT for the Harvard/UCSF ROBIN Center
- University of California, San Francisco, San Francisco
Recruiting
All ages · All sexes · Updated Feb 17, 2025 · NCT06000787The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- University of California, San Francisco (UCSF), San Francisco
RecruitingObservational study
Ages 18 to 90 · All sexes · Updated Feb 22, 2024 · NCT06118723From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.